Global In-Vitro Diagnostics Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,475	169 Pages	Evolve Business Intelligence	October, 2024	EVBI19261160

Best Price Guarantee
Price	from $3,475
Length	169 Pages
Publisher	Evolve Business Intelligence
Published Date	October, 2024
SKU	EVBI19261160

Global In-Vitro Diagnostics Market

Global In-vitro diagnostics (IVD) Market By Offerings (Reagents, Instruments, and Software And Services), By Technology (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Microbiology, Coagulation & Hemostasis, and Others), By Application (Infectious Diseases, Oncology, Endocrinology, Cardiology, Blood Screening, Genetic Testing, Autoimmune Diseases, Allergy Diagnostics, Bone & Mineral Disorders, Coagulation Testing, and Others) , By End User (Hospital & Clinics, Clinical Laboratories, Point of Care, Pharmaceutical & Biotechnology Companies, Academic Institutes, and Others) And By Geography – Covid-19 Impact Analysis, Post Covid Analysis, Opportunities, Trends And Forecast From 2021 to 2034

The global In-Vitro Diagnostics market was valued at $92.1 billion in 2023 and is anticipated to grow at a CAGR of 7.2% from 2024 to 2034. This growth is attributed to several macro and microeconomic factors such as

Rising numbers of Infectious Diseases and Chronic Disease

One of the foremost factors driving the growth of the In-Vitro Diagnostics (IVD) market is the increasing incidence of infectious diseases globally. Infectious diseases, such as HIV, tuberculosis, malaria, and more recently, COVID-19, have underscored the critical need for reliable, rapid, and accurate diagnostic tools. The COVID-19 pandemic, in particular, highlighted the importance of molecular diagnostics like PCR tests, which became essential for detecting and controlling the spread of the virus. This heightened awareness and the subsequent investment in diagnostic infrastructure are expected to have a lasting impact on the IVD market. Furthermore, the ongoing threat of emerging and re-emerging pathogens demands continuous advancements in diagnostic technologies to ensure timely and effective responses to future outbreaks. The demand for diagnostics in infectious disease management extends beyond just identifying the presence of pathogens. It includes monitoring disease progression, guiding treatment decisions, and conducting surveillance to track the spread and evolution of diseases. Innovations in molecular diagnostics, such as next-generation sequencing (NGS), have enabled more comprehensive and precise pathogen detection, including the identification of new variants and antimicrobial resistance genes. These advancements are crucial for implementing effective public health measures and personalized treatment plans, further driving the growth of the IVD market.

Further several factors restraining the market growth include

Rise in Aging Population

The aging population is a significant driver of growth in the In-Vitro Diagnostics (IVD) market, majorly due to the demand for diagnostic tests and technologies. People are more prone to developing chronic diseases such as cardiovascular diseases, diabetes, cancer, and neurodegenerative disorders due to aging. These conditions often require regular monitoring and early diagnosis to manage effectively. IVD plays a vital role in detecting these diseases at an early stage, enabling timely interventions and improving patient outcomes. Consequently, the increasing number of elderly individuals globally has led to a higher demand for various diagnostic tests, propelling the growth of the IVD market. As the global population ages, the incidence of conditions such as hypertension, diabetes, and osteoporosis rises. These conditions often necessitate routine blood tests, urine tests, and other diagnostic procedures to monitor disease progression and manage treatment. For instance, diabetic patients require regular blood glucose monitoring, while those with cardiovascular conditions need lipid profile tests. The growing burden of these chronic diseases among the elderly population has significantly contributed to the expansion of the IVD market, as healthcare providers rely on diagnostic tests to deliver effective care.

Growth in untapped emerging markets and the rise of personalized medicine are expected to generate higher avenues during the forecast period.

In the wake of the COVID-19 pandemic, supply chain disruptions have led to supply shortages or lower demand in the In-vitro diagnostics (IVD) market. The pandemic has caused a decline in new orders and a corresponding decrease in production.

This section will analyze how COVID-19 has impacted supply chains, leading to shortages and lower demand for In-vitro diagnostics (IVD).

In terms of COVID-19 impact, the In-vitro diagnostics (IVD) market report also includes the following data points:

Impact on In-vitro diagnostics (IVD) market size
Operating Weights Trend, Preferences, and Budget Impact
Regulatory Framework/Outdoor Policies
Key Players' Strategy to Tackle Negative Impact/Post-COVID Strategies
Opportunity in the In-vitro diagnostics (IVD) market

Key Insight in the report:

The global In-vitro diagnostics (IVD) market report covers an executive summary, market dynamics, COVID impact & post-COVID scenario, market size and forecast, competitive intelligence, market positioning, and Product Types.

Our report covers extensive competitive intelligence which includes the following data points:

Business Overview
Business Segment Data
Financial Data
Product Type Segment Analysis and Specification
Recent Development and Company Strategy Analysis
SWOT Analysis

In-vitro diagnostics (IVD) Market Segmentation:

Offerings
Reagents
Instruments
Software And Services
Technology
Immunodiagnostics
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Chemistry
Microbiology
Coagulation & Hemostasis
Others
Application
Infectious Diseases
Oncology
Endocrinology
Cardiology
Blood Screening
Genetic Testing
Autoimmune Diseases
Allergy Diagnostics
Bone & Mineral Disorders
Coagulation Testing
Others
End User
Hospital & Clinics
Clinical Laboratories
Point of Care
Pharmaceutical & Biotechnology Companies
Academic Institutes
Others

Region/ Countries Covered:

North America
US
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
BeNeLux
Nordic
Rest of Europe
Asia Pacific
China
Japan
Australia
India
South Korea
Thailand
Indonesia
Malaysia
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Egypt
South Africa
Rest of Middle East & Africa

Key Players Analyzed in the Report:

Abbott Laboratories
Becton, Dickinson and Company
bioMérieux
Bio-Rad Laboratories Inc
Danaher Corporation (Beckman Coulter, Inc.)
Hoffmann-La Roche
Siemens
QIAGEN N.V.
Sysmex Corporation
Thermo Fisher Scientific Inc

CHAPTER 1. Executive Summary
CHAPTER 2. Scope of the Study: 2.1. Market Definition; 2.2. Market Scope & Segmentation; 2.2.1. Objective of Report
CHAPTER 3. Evolve BI Methodology: 3.1. Data Collection & Validation Approach; 3.2. Market Size Estimation and Forecast
CHAPTER 4. Market Insights and Trends: 4.1. Value Chain Analysis; 4.1.1. Research & Development; 4.1.2. Manufacturing Process; 4.1.3. Distribution Channel; 4.1.4. End-User; 4.2. Porter’s Five Forces Analysis; 4.2.1. Bargaining Power of Buyers; 4.2.2. Bargaining Power of Suppliers; 4.2.3. Threat of New Entrant; 4.2.4. Threat of Substitute; 4.2.5. Industry Rivalry; 4.3. COVID-19 Impact and Post COVID Scenario on In-Vitro Diagnostics Market; 4.3.1. Impact of COVID-19; 4.3.2. Government Support and Industry Revival Policies; 4.3.3. Measures Taken by Companies to Mitigate Negative Impact; 4.3.4. Post COVID Trend
CHAPTER 5. Market Dynamics: 5.1. Introduction; 5.2. Drivers; 5.2.1. Rising numbers of Infectious Diseases and Chronic Disease; 5.2.2. Rise in Aging Population; 5.2.3. Increased Healthcare Spending; 5.3. Restraints; 5.3.1. Unfavorable Reimbursement Scenarios; 5.3.2. Rising Healthcare Costs; 5.4. Opportunity; 5.4.1. Growth in untapped emerging markets; 5.4.2. The rise of personalized medicine
CHAPTER 6. Global In-Vitro Diagnostics Market, By Product And Instruments & Software And Services: 6.1. Introduction; 6.1.1. Reagents; 6.1.2. Instruments; 6.1.3. Software And Services
CHAPTER 7. Global In-Vitro Diagnostics Market, By Technology: 7.1. Introduction; 7.1.1. Immunodiagnostics; 7.1.2. Hematology; 7.1.3. Molecular Diagnostics; 7.1.4. Tissue Diagnostics; 7.1.5. Clinical Chemistry; 7.1.6. Microbiology; 7.1.7. Coagulation & Hemostasis; 7.1.8. Others
CHAPTER 8. Global In-Vitro Diagnostics Market, By Application: 8.1. Introduction; 8.1.1. Infectious Diseases; 8.1.2. Oncology; 8.1.3. Endocrinology; 8.1.4. Cardiology; 8.1.5. Blood Screening; 8.1.6. Genetic Testing; 8.1.7. Autoimmune Diseases; 8.1.8. Allergy Diagnostics; 8.1.9. Bone & Mineral Disorders; 8.1.10. Coagulation Testing; 8.1.11. Others
CHAPTER 9. Global In-Vitro Diagnostics Market, By End User: 9.1. Introduction; 9.1.1. Hospital & Clinics; 9.1.2. Clinical Laboratories; 9.1.3. Point of Care; 9.1.4. Pharmaceutical & Biotechnology Companies; 9.1.5. Academic Institutes; 9.1.6. Others
CHAPTER 10. Global In-Vitro Diagnostics Market, By Region: 10.1. Introduction; 10.2. North America; 10.2.1. North America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million); 10.2.2. North America: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.2.3. North America: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.2.4. North America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.2.5. North America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.2.6. US; 10.2.6.1. U.S.: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.2.6.2. U.S.: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.2.6.3. U.S.: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.2.6.4. U.S.: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.2.7. Canada; 10.2.7.1. Canada: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.2.7.2. Canada: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.2.7.3. Canada: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.2.7.4. Canada: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.2.8. Mexico; 10.2.8.1. Mexico: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.2.8.2. Mexico: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.2.8.3. Mexico: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.2.8.4. Mexico: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3. Europe; 10.3.1. Europe: Market Size and Forecast, By Country, 2021 – 2034 ($ Million); 10.3.2. Europe: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.3. Europe: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.4. Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.5. Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.6. U.K.; 10.3.6.1. U.K.: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.6.2. U.K.: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.6.3. U.K.: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.6.4. U.K.: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.7. Germany; 10.3.7.1. Germany: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.7.2. Germany: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.7.3. Germany: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.7.4. Germany: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.8. France; 10.3.8.1. France: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.8.2. France: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.8.3. France: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.8.4. France: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.9. Italy; 10.3.9.1. Italy: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.9.2. Italy: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.9.3. Italy: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.9.4. Italy: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.10. Spain; 10.3.10.1. Spain: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.10.2. Spain: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.10.3. Spain: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.10.4. Spain: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.11. BeNeLux; 10.3.11.1. BeNeLux: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.11.2. BeNeLux: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.11.3. BeNeLux: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.11.4. BeNeLux: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.12. Russia; 10.3.12.1. Russia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.12.2. Russia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.12.3. Russia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.12.4. Russia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.3.13. Rest of Europe; 10.3.13.1. Rest of Europe: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.3.13.2. Rest of Europe: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.3.13.3. Rest of Europe: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.3.13.4. Rest of Europe: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4. Asia Pacific; 10.4.1. Asia Pacific: Market Size and Forecast, By Country, 2021 – 2034 ($ Million); 10.4.2. Asia Pacific: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.3. Asia Pacific: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.4. Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.5. Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.6. China; 10.4.6.1. China: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.6.2. China: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.6.3. China: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.6.4. China: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.7. Japan; 10.4.7.1. Japan: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.7.2. Japan: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.7.3. Japan: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.7.4. Japan: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.8. Australia; 10.4.8.1. Australia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.8.2. Australia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.8.3. Australia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.8.4. Australia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.9. India; 10.4.9.1. India: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.9.2. India: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.9.3. India: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.9.4. India: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.10. South Korea; 10.4.10.1. South Korea: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.10.2. South Korea: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.10.3. South Korea: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.10.4. South Korea: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.11. Malaysia; 10.4.11.1. Malaysia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.11.2. Malaysia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.11.3. Malaysia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.11.4. Malaysia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.12. Thailand; 10.4.12.1. Thailand: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.12.2. Thailand: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.12.3. Thailand: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.12.4. Thailand: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.13. Indonesia; 10.4.13.1. Indonesia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.13.2. Indonesia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.13.3. Indonesia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.13.4. Indonesia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.4.14. Rest of Asia Pacific; 10.4.14.1. Rest of Asia Pacific: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.4.14.2. Rest of Asia Pacific: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.4.14.3. Rest of Asia Pacific: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.4.14.4. Rest of Asia Pacific: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.5. South America; 10.5.1. South America: Market Size and Forecast, By Country, 2021 – 2034 ($ Million); 10.5.2. South America: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.5.3. South America: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.5.4. South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.5.5. South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.5.6. Brazil; 10.5.6.1. Brazil: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.5.6.2. Brazil: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.5.6.3. Brazil: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.5.6.4. Brazil: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.5.7. Argentina; 10.5.7.1. Argentina: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.5.7.2. Argentina: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.5.7.3. Argentina: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.5.7.4. Argentina: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.5.8. Rest of South America; 10.5.8.1. Rest of South America: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.5.8.2. Rest of South America: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.5.8.3. Rest of South America: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.5.8.4. Rest of South America: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.6. Middle East & Africa; 10.6.1. Middle East & Africa: Market Size and Forecast, By Country, 2021 – 2034 ($ Million); 10.6.2. Middle East & Africa: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.6.3. Middle East & Africa: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.6.4. Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.6.5. Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.6.6. Saudi Arabia; 10.6.6.1. Saudi Arabia: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.6.6.2. Saudi Arabia: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.6.6.3. Saudi Arabia: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.6.6.4. Saudi Arabia: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.6.7. UAE; 10.6.7.1. UAE: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.6.7.2. UAE: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.6.7.3. UAE: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.6.7.4. UAE: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.6.8. Egypt; 10.6.8.1. Egypt: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.6.8.2. Egypt: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.6.8.3. Egypt: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.6.8.4. Egypt: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.6.9. South Africa; 10.6.9.1. South Africa: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.6.9.2. South Africa: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.6.9.3. South Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.6.9.4. South Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million); 10.6.10. Rest of Middle East & Africa; 10.6.10.1. Rest of Middle East & Africa: Market Size and Forecast, By Offerings, 2021 – 2034 ($ Million); 10.6.10.2. Rest of Middle East & Africa: Market Size and Forecast, By Technology, 2021 – 2034 ($ Million); 10.6.10.3. Rest of Middle East & Africa: Market Size and Forecast, By Application, 2021 – 2034 ($ Million); 10.6.10.4. Rest of Middle East & Africa: Market Size and Forecast, By End User, 2021 – 2034 ($ Million)
CHAPTER 11. Competitive Landscape: 11.1. Competitior Benchmarking 2023; 11.2. Market Share Analysis, 2022; 11.3. Key Developments Analysis By Top 5 Companies; 11.4. Market Share Acquisition Strategies: Analysis of Key Approaches Employed by Top Players
CHAPTER 12. Company Profiles: 12.1. Abbott Laboratories; 12.1.1. Business Overview; 12.1.2. Financial Analysis12.1.2.1. Business Segment Revenue, 2023; 12.1.2.2. Geographic Revenue Mix, 2023; 12.1.3. Product Portfolio; 12.1.4. Recent Development and Strategies Adopted; 12.1.5. SWOT Analysis; 12.2. Becton, Dickinson, and Company; 12.2.1. Business Overview; 12.2.2. Financial Analysis; 12.2.2.1. Business Segment Revenue, 2023; 12.2.2.2. Geographic Revenue Mix, 2023; 12.2.3. Product Portfolio; 12.2.4. Recent Development and Strategies Adopted; 12.2.5. SWOT Analysis; 12.3. BIOMERIEUX; 12.3.1. Business Overview; 12.3.2. Financial Analysis; 12.3.2.1. Business Segment Revenue, 2023; 12.3.2.2. Geographic Revenue Mix, 2023; 12.3.3. Product Portfolio; 12.3.4. Recent Development and Strategies Adopted; 12.4. Bio-Rad Laboratories Inc; 12.4.1. Business Overview; 12.4.2. Financial Analysis; 12.4.2.1. Business Segment Revenue, 2023; 12.4.2.2. Geographic Revenue Mix, 2023; 12.4.3. Product Portfolio; 12.4.4. Recent Development and Strategies Adopted; 12.5. Danaher Corporation; 12.5.1. Business Overview; 12.5.2. Financial Analysis; 12.5.2.1. Business Segment Revenue, 2023; 12.5.2.2. Geographic Revenue Mix, 2023; 12.5.3. Product Portfolio; 12.5.4. Recent Development and Strategies Adopted; 12.5.5. SWOT Analysis; 12.6. Hoffmann-La Roche; 12.6.1. Business Overview; 12.6.2. Financial Analysis; 12.6.2.1. Business Segment Revenue, 2023; 12.6.2.2. Geographic Revenue Mix, 2023; 12.6.3. Product Portfolio; 12.6.4. Recent Development and Strategies Adopted; 12.6.5. SWOT Analysis; 12.7. Siemens Healthineers AG; 12.7.1. Business Overview; 12.7.2. Financial Analysis; 12.7.2.1. Business Segment Revenue, 2023; 12.7.2.2. Geographic Revenue Mix, 2023; 12.7.3. Product Portfolio; 12.7.4. Recent Development and Strategies Adopted; 12.8. QIAGEN N.V.; 12.8.1. Business Overview; 12.8.2. Financial Analysis; 12.8.2.1. Business Segment Revenue, 2023; 12.8.2.2. Geographic Revenue Mix, 2023; 12.8.3. Product Portfolio; 12.8.4. Recent Development and Strategies Adopted; 12.9. Sysmex Corporation; 12.9.1. Business Overview; 12.9.2. Financial Analysis; 12.9.2.1. Geographic Revenue Mix, 2023; 12.9.3. Product Portfolio; 12.9.4. Recent Development and Strategies Adopted; 12.10. THERMO FISHER SCIENTIFIC INC; 12.10.1. Business Overview; 12.10.2. Financial Analysis; 12.10.2.1. Business Segment Revenue, 2023; 12.10.2.2. Geographic Revenue Mix, 2023; 12.10.3. Product Portfolio; 12.10.4. Recent Development and Strategies Adopted; 12.10.5. SWOT Analysis